Guidelines on prophylaxis to prevent infective endocarditis by Thornhill, M.H. et al.
This is a repository copy of Guidelines on prophylaxis to prevent infective endocarditis.




Thornhill, M.H., Dayer, M., Lockhart, P.B. et al. (4 more authors) (2016) Guidelines on 






Unless indicated otherwise, fulltext items are protected by copyright with all rights reserved. The copyright 
exception in section 29 of the Copyright, Designs and Patents Act 1988 allows the making of a single copy 
solely for the purpose of non-commercial research or private study within the limits of fair dealing. The 
publisher or other rights-holder may allow further reproduction and re-use of this version - refer to the White 
Rose Research Online record for this item. Where records identify the publisher as the copyright holder, 
users can verify any specific terms of use on the publisher’s website. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 









































































































































































































































































































































































































































































































































































































































• There are approximately 2,150 cases of infective endocarditis in the UK annually 
• The incidence of infective endocarditis is rising 
• 15-20% of infective endocarditis patients die during their initial hospital admission 
• A further 10-15% die over the following year 
• 35-45% of cases are caused by oral viridans group Streptococci 
• A similar proportion are caused by skin related Staphylococci 
• 40-45% require surgery during the initial hospital admission, often involving prosthetic 
replacement of one or more heart valves, and a further 10% need surgery in the year 
after discharge 
• Many survivors will have significantly reduced quality and length of life 















Patients at Increased Risk of Developing Infective Endocarditis 
High-Risk: 
1. Patients with a previous history of infective endocarditis 
2. Patients with any form of prosthetic heart valve (including a transcatheter valve) 
3. Those in whom prosthetic material was used for cardiac valve repair 
4. Patients with any type of cyanotic congenital heart disease 
5. Patients with any type of congenital heart disease repaired with prosthetic material, 
whether placed surgically or by percutaneous techniques, for the first 6 months after 
the procedure or lifelong if a residual shunt or valvular regurgitation remains 
Moderate-Risk:  
1. Patients with a previous history of rheumatic fever 
2. Patients with any other form of native valve disease (including the most commonly 
identified conditions: bicuspid aortic valve, mitral valve prolapse and calcific aortic 
stenosis) 
3. Patients with unrepaired congenital anomalies of the heart valves 
Note: 
ESC only recommends antibiotic prophylaxis for high-risk patients. Non-specific prevention 
measures are recommended for both groups 
This table has been adapted from the 2015 ESC Guidelines for the management of infective 
endocarditis
8
 with the permission of Oxford University Press (UK) and the European Society 














Antibiotic prophylaxis should only be considered for dental procedures requiring 
manipulation of the gingival (including extractions and scaling) or periapical region of the 
teeth (including root canal procedures) or perforation of the oral mucosa 
NOT Considered High-Risk:  
Antibiotic prophylaxis is not recommended for: 
• Local anaesthetic injections in non-infected tissue 
• Treatment of superficial caries i.e. not requiring gingival manipulation 
• Removal of sutures 
• Dental X-rays 
• Placement or adjustment of removable prosthodontics or orthodontic appliance or 
braces 
• Following shedding of deciduous teeth 
• Following trauma to the lips or oral mucosa 
Note: 
ESC does not recommend antibiotic prophylaxis for any non-dental procedures 
This table has been adapted from the 2015 ESC Guidelines for the management of infective 
endocarditis
8














Recommended Antibiotic Prophylaxis for High-Risk Dental Procedures 
in High-Risk Patients 
Situation Antibiotic 
Single-dose 30-60 minutes before procedure 
Adults Children 
No allergy to 






 or i.v. 50mg/kg orally or i.v. 
Allergy to penicillin or 
ampicillin 
Clindamycin 600mg orally or i.v. 20mg/kg orally or i.v. 
Notes: 
1. Alternatively, cephalexin 2g i.v. for adults or 50mg/kg i.v. for children, cefazolin or ceftriaxone 1g i.v. for adults or 
50mg/kg i.v. for children. Cephalosporins should not be used, however, in patients with anaphylaxis, angio-
oedema or urticarial after intake of penicillin or ampicillin due to cross-sensitivity. 
2. In the UK, a practical alternative is the 3g amoxicillin oral powder sachet to be made up with water. 
This table has been adapted from the 2015 ESC Guidelines for the management of infective 
endocarditis
8














Symptoms of Endocarditis 
Presentation: 
There are two ways symptoms of endocarditis can develop: 
• Over the course of a few days, rapidly getting worse (acute endocarditis) 
• Slowly, over the course of a few weeks or possibly months (subacute endocarditis) 
Symptoms of Endocarditis:  
• High temperature of 38C or above 
• Night sweats 
• Shortness of breath on exertion 
• Tiredness (fatigue) 
• Muscle and joint pains 
• Unexplained weight loss 
Other possible symptoms and signs: 
• The development of a new or worsening heart murmur 
• The appearance of a spotty red rash on the skin (petechiae) 
• Narrow, reddish-brown streaks under the nails (splinter haemorrhages) 
• Red tender lesions under the skin of the fingers or toes (Osler’s nodes) 
• Confusion 
• Stroke 
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